Therapeutic drug monitoring and drug-drug interactions involving antiretroviral drugs.
about
Plasma concentrations of efavirenz and nevirapine among HIV-infected patients with immunological failure attending a tertiary hospital in North-western TanzaniaEffect of rifampin on steady-state pharmacokinetics of atazanavir with ritonavir in healthy volunteers.Therapeutic drug monitoring of protease inhibitors and efavirenz in HIV-infected individuals with active substance-related disorders.A randomized clinical trial evaluating therapeutic drug monitoring (TDM) for protease inhibitor-based regimens in antiretroviral-experienced HIV-infected individuals: week 48 results of the A5146 study.Human hepatocyte assessment of imatinib drug-drug interactions - complexities in clinical translation.Management of patients with HIV in the intensive care unitPlasma and intracellular pharmacokinetics of darunavir/ritonavir once daily and raltegravir once and twice daily in HIV-infected individuals.Pharmacokinetics of abacavir and its anabolite carbovir triphosphate without and with darunavir/ritonavir or raltegravir in HIV-infected subjects.Ritonavir and efavirenz significantly alter the metabolism of erlotinib--an observation in primary cultures of human hepatocytes that is relevant to HIV patients with cancer.Antiretroviral drug interactions: overview of interactions involving new and investigational agents and the role of therapeutic drug monitoring for management.Pharmacogenomics of CYP3A: considerations for HIV treatment.Availability of nutritional support services in HIV care and treatment sites in sub-Saharan African countries.
P2860
Q28533168-A36926A1-2EA5-417E-BFF6-770793326C99Q30478126-41DE2E91-186E-4FBC-BD34-670F0269CE89Q35061983-CCF62975-CD23-4EF7-846F-FA97FDBB14E8Q35894312-6957B5C3-594E-48FB-9E17-C83D6F9F951FQ36243653-9890B0ED-88E1-4A20-8B33-E764A3ECE970Q36403151-85F4057E-1F30-4993-9787-703E279199E7Q36675900-81582905-717F-4810-8D68-BA29CC79FAC8Q37077340-0A3A7FB2-C827-4F8C-AE73-3E136696DBA5Q37193103-A0F8790C-9082-4525-9B11-C24822616038Q37378110-C38B2B9D-6CDD-40A1-AFA0-DD87C8DD6C9FQ37419542-0039D0EA-F126-4EEC-8ACE-DB4471B590D7Q37685937-DA37C588-5CAF-45AE-9444-5BDD040AB5A9
P2860
Therapeutic drug monitoring and drug-drug interactions involving antiretroviral drugs.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Therapeutic drug monitoring and drug-drug interactions involving antiretroviral drugs.
@ast
Therapeutic drug monitoring and drug-drug interactions involving antiretroviral drugs.
@en
type
label
Therapeutic drug monitoring and drug-drug interactions involving antiretroviral drugs.
@ast
Therapeutic drug monitoring and drug-drug interactions involving antiretroviral drugs.
@en
prefLabel
Therapeutic drug monitoring and drug-drug interactions involving antiretroviral drugs.
@ast
Therapeutic drug monitoring and drug-drug interactions involving antiretroviral drugs.
@en
P2093
P1433
P1476
Therapeutic drug monitoring and drug-drug interactions involving antiretroviral drugs
@en
P2093
Charles Flexner
Courtney V Fletcher
David Back
David Burger
Edward Acosta
Gilles Peytavin
Giorgio Gatti
Mario Regazzi
Marta Boffito
Michael Kurowski
P304
P577
2005-01-01T00:00:00Z